$2.47
0.40%
NYSE, Sep 28, 04:00 pm EDT. Closed.
ISIN
US36870H1032
Symbol
GNLX

Genelux Target price 2026 - Analyst rating & recommendation

Genelux Classifications & Recommendation

Buy
91%
Hold
9%

Genelux Price Target

Target Price $16.32
Price $2.47
Potential
Number of Estimates 8
8 Analysts have issued a price target Genelux 2027 . The average Genelux target price is $16.32. This is higher than the current stock price. The highest price target is
$32.55 1,217.81%
register free of charge
, the lowest is .
A rating was issued by 11 analysts: 10 Analysts recommend Genelux to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Genelux stock has an average upside potential 2027 of . Most analysts recommend the Genelux stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ -0.86 -0.84
9.47% 2.33%
P/E negative

8 Analysts have issued a Genelux forecast for earnings per share. The average Genelux EPS is

$-0.84
unlock
. This is
6.33% lower
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$-0.81 2.53%
unlock
, the lowest is
$-0.89 12.66%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $-0.86 9.47%
2026
$-0.84 2.33%
unlock
2027
$-0.76 9.52%
unlock
2028
$0.12 115.79%
unlock
2029
$0.72 500.00%
unlock
2030
$1.55 115.28%
unlock
2031
$5.72 269.03%
unlock
2032
$7.64 33.57%
unlock

P/E ratio

Current -3.13 40.45%
2026
-2.95 5.65%
unlock
2027
-3.25 10.17%
unlock
2028
21.06 748.00%
unlock
2029
3.41 83.81%
unlock
2030
1.59 53.37%
unlock
2031
0.43 72.96%
unlock
2032
0.32 25.58%
unlock

Current Genelux Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Benchmark
Locked
➜
Locked
Locked Mar 20 2026
Lake Street
Locked
➜
Locked
Locked Oct 21 2025
LUCID CAPITAL MARKETS
Locked
➜
Locked
Locked Jul 21 2025
Benchmark
Locked
➜
Locked
Locked May 08 2025
HC Wainwright & Co.
Locked
➜
Locked
Locked Mar 31 2025
HC Wainwright & Co.
Locked
➜
Locked
Locked Mar 25 2025
HC Wainwright & Co.
Locked
➜
Locked
Locked Nov 15 2024
Analyst Rating Date
Locked
Benchmark:
Locked
➜
Locked
Mar 20 2026
Locked
Lake Street:
Locked
➜
Locked
Oct 21 2025
Locked
LUCID CAPITAL MARKETS:
Locked
➜
Locked
Jul 21 2025
Locked
Benchmark:
Locked
➜
Locked
May 08 2025
Locked
HC Wainwright & Co.:
Locked
➜
Locked
Mar 31 2025
Locked
HC Wainwright & Co.:
Locked
➜
Locked
Mar 25 2025
Locked
HC Wainwright & Co.:
Locked
➜
Locked
Nov 15 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today